HopeStage
Back to overview

Schizophrenia studies

Topics
More filters

Schizophrenia

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

4505studies shown
Showing 3,085-3,096 of 4,505
Drug study icon
CompletedNCT04306146

CAD-9303 in Subjects With Schizophrenia

Official study title

A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Effects on Neurophysiological Biomarkers of CAD-9303 Oral Treatment in Subjects With Schizophrenia and Normal Healthy Volunteers

This study has finished and is no longer accepting participants.

Multiple locations, including Long Beach
SchizophreniaMedication studyAges 18–50
Countries
United States
Sponsor
Cadent Therapeutics
Device study icon
CompletedNCT03751280

Efficacy of PEAR-004 in Schizophrenia

Official study title

A Randomized, Sham-Controlled Study of PEAR-004 as an Adjunct to Standard-of-care Treatment for Schizophrenia

This study has finished and is no longer accepting participants.

Multiple locations, including Garden Grove
SchizophreniaDevice studyAges 18–65
Countries
United States
Sponsor
Novartis Pharmaceuticals
Device study icon
CompletedNCT03064776

m-RESIST, an m-Health Program for Treatment-resistant Schizophrenia

Official study title

Pilot Study of m-RESIST, an m-Health Program for Treatment-resistant Schizophrenia: Acceptability, Usability, Satisfaction and Perceived Quality of Life Reported by Patients and Caregivers

This study has finished and is no longer accepting participants.

Multiple locations, including Budapest
SchizophreniaDevice studyAges 18–45
Countries
Hungary, Israel, Spain
Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Other study type icon
CompletedNCT02897167

the Activation of Proinflammatory Pathways of Toll-like Receptors in Schizophrenia Patients

Official study title

Retrospective and Prospective Study of the Activation of Proinflammatory Pathways of Toll-like Receptors in Patients With Schizophrenia: a Comparative Effect of Risperidone vs Aripiprazole

This study has finished and is no longer accepting participants.

In Santander
SchizophreniaObservational studyAges 15–50
Countries
Spain
Sponsor
Fundación Marques de Valdecilla
Drug study icon
CompletedNCT02876900

HP3070 for schizophrenia

Official study title

A Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose, 6-Week, In-Patient Study to Assess Efficacy and Safety of HP-3070 in Subjects Diagnosed With Schizophrenia

This study has finished and is no longer accepting participants.

In Jersey City
SchizophreniaMedication studyAges 18+
Countries
United States
Sponsor
Noven Pharmaceuticals, Inc.
Drug study icon
CompletedNCT03150771

Pharmacokinetics, Safety & Tolerability of Aripiprazole in Adults With Schizophrenia

What is this study about?

This study evaluated the safety of Aripiprazole for people with schizophrenia.

This study has finished and is no longer accepting participants.

Multiple locations, including Little Rock
SchizophreniaMedication studyAges 18–64
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
Drug study icon
CompletedNCT00535132

Medication satisfaction after switching from risperidone to paliperidone

About this title

Study to Measure Drug Satisfaction of Patients With Schizophrenia After Switching From Risperidone to Paliperidone

Read the official source — NCT00535132
Official study title

A Blinded-initiation Study of Medication Satisfaction in Subjects With Schizophrenia Treated With Paliperidone ER After Suboptimal Response to Oral Risperidone

This study has finished and is no longer accepting participants.

Multiple locations, including Cerritos
SchizophreniaMedication studyAges 18+
Countries
United States, Argentina, Colombia, + 3 others
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.